Back to top

Hikma Advances $250m Buyback, Tightens Share Base

Hikma Pharmaceuticals ( ($GB:HIK) ) has issued an update. Hikma Pharmaceuticals has continued the second tranche of its $250 million share repurcha...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Hikma Pharmaceuticals Plc (HKMPF)